Our new preprint about off-target edits from therapeutic CRISPR base editors editors used in gene therapies is out! Tong Wang developed a new method, beCasKAS to sensitively detect off-target sites, and I show how non-coding edits can be triaged for epigenetic dysregulation using deep learning.